BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29963684)

  • 1. Treatment of Actinic Keratosis with Photodynamic Therapy Using Red or Green Light: A Comparative Study.
    Osiecka BJ; Nockowski P; Szepietowski JC
    Acta Derm Venereol; 2018 Jul; 98(7):689-693. PubMed ID: 29963684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
    Serra-Guillén C; Nagore E; Bancalari E; Kindem S; Sanmartín O; Llombart B; Requena C; Serra-Guillén I; Calomarde L; Diago A; Bernia E; Guillén C
    Br J Dermatol; 2018 Dec; 179(6):1410-1411. PubMed ID: 30019337
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Acta Derm Venereol; 2017 May; 97(5):617-621. PubMed ID: 28093604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
    Kellner C; Bauriedl S; Hollstein S; Reinhold U
    Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
    Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
    Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red light ALA-PDT for large areas of actinic keratosis is limited by severe pain and patient dissatisfaction.
    Middelburg TA; Nijsten T; Neumann MH; de Haas ER; Robinson DJ
    Photodermatol Photoimmunol Photomed; 2013 Oct; 29(5):276-8. PubMed ID: 24001386
    [No Abstract]   [Full Text] [Related]  

  • 15. Photodynamic therapy with the use of superluminescent diodes (sLED) in the treatment of actinic keratosis.
    Bartosińska J; Wolska-Gawron K; Gerkowicz A; Niewiedzioł M; Michalska-Jakubus M; Komza M; Klepaczewski T; Kwaśny M; Krasowska D
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():187-190. PubMed ID: 29684690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
    Yazdanyar S; Zarchi K; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
    Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
    Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
    Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
    Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?
    Kessels JP; Nelemans PJ; Mosterd K; Kelleners-Smeets NW; Krekels GA; Ostertag JU
    Acta Derm Venereol; 2016 Mar; 96(3):351-4. PubMed ID: 26551377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.